AW
CRDF icon

Avion Wealth’s Cardiff Oncology CRDF Stock Holding History

Avion Wealth’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-225
Closed – – 1306
2025
Q4 		$0 Buy
+225
New +$522 ﹤0.01% 1300

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Avion Wealth's CRDF Position: Q1 2026 in Review

Avion Wealth sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 225 shares.

Avion Wealth first reported a position in CRDF in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Avion Wealth reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • Avion Wealth sold 225 Cardiff Oncology shares in Q1 2026.
  • Avion Wealth first reported a position in Cardiff Oncology in Q4 2025 and held it in 1 quarter.
  • Avion Wealth's Cardiff Oncology position peaked at $0 in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.